2008
DOI: 10.2174/138955708783331559
|View full text |Cite
|
Sign up to set email alerts
|

Bacterial β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH): An Attractive Target for the Design of New Broad-Spectrum Antimicrobial Agents

Abstract: The emergence of drug resistant strains of important human pathogens has made urgent the necessity of finding new targets and novel antimicrobial agents. One of the most promising targets is FabH. In this review we summarize the progress made in the design of FabH inhibitors and the role played by the 3D-structure of the enzyme in the drug design process.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(4 citation statements)
references
References 33 publications
0
4
0
Order By: Relevance
“…FabH, which encodes 3-oxoacyl-(acyl-carrier-protein) synthase, is essential in the absence of long chain fatty acids in some species, such as E. coli , but not in others, such as Pseudomonas aeruginosa [30], [31], and has been identified as a promising drug target in pathogenic bacteria [32]. The B. thailandensis FabH gene (BTH_I1717) was among the group of genes we identified as essential for in vitro growth using rich medium.…”
Section: Resultsmentioning
confidence: 99%
“…FabH, which encodes 3-oxoacyl-(acyl-carrier-protein) synthase, is essential in the absence of long chain fatty acids in some species, such as E. coli , but not in others, such as Pseudomonas aeruginosa [30], [31], and has been identified as a promising drug target in pathogenic bacteria [32]. The B. thailandensis FabH gene (BTH_I1717) was among the group of genes we identified as essential for in vitro growth using rich medium.…”
Section: Resultsmentioning
confidence: 99%
“…FabH, also known as β-ketoacyl-(acyl-carrier-protein)synthase III (KAS III), is a key enzyme involved in the biosynthesis of bacterial fatty acids, being responsible for the first condensation reaction between acetyl-coA and malonyl-acyl carrier protein (ACP), with the formation of acetoacetyl-ACP. FabH is found in many bacterial pathogens including Escherichia coli, Staphylococcus aureus, Mycobacterium tuberculosis, Enterococcus faecium, Streptococcus pneumoniae, Pseudomonas aeruginosa, Neisseria meningitidis, and Haemophilus influenzae, most of them possessing high levels of resistance to currently authorized antimicrobial drugs [56]. The three-dimensional structure of the FabH protein is well preserved among many Gram-positive and Gram-negative bacteria.…”
Section: Antimicrobial Activitymentioning
confidence: 99%
“…Our results suggest that HOS2 and other histone deacetylases (such as RPD3) are potential antifungal drug targets [ 86 , 87 , 88 ]. Additionally, FABH is an essential enzyme for the synthesis of fatty acids in bacteria, and it has been investigated for its potential as a drug target [ 89 ]. In the specific case of S. aureus , FABH has been validated as a target of many chemical compounds presenting antibacterial activity [ 90 , 91 , 92 , 93 ].…”
Section: Discussionmentioning
confidence: 99%